Biohaven logo

Biohaven Share Price (NYSE: BHVN)

$15.39

-0.13

(-0.84%)

Last updated on

Check the interactive Biohaven Stock chart to analyse performance

Biohaven stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$15.31
    Today's High:$15.70

    Day's Volatility :2.48%

  • 52 Weeks Low:$12.79
    52 Weeks High:$55.70

    52 Weeks Volatility :77.04%

Biohaven Stock Returns

PeriodBiohaven LtdIndex (Russel 2000)
3 Months
-1.79%
0.0%
6 Months
-51.97%
0.0%
1 Year
-59.65%
0.0%
3 Years
-89.72%
-4.7%

Biohaven Ltd Key Stats

Check Biohaven key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$15.52
Open
$15.66
Today's High
$15.7
Today's Low
$15.31
Market Capitalization
$1.6B
Today's Volume
$999.6K
52 Week High
$55.7
52 Week Low
$12.79
Revenue TTM
$0.0
EBITDA
$-928.7M
Earnings Per Share (EPS)
$-7.46
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-295.94%

Stock Returns calculator for Biohaven Stock including INR - Dollar returns

The Biohaven stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Biohaven investment value today

Current value as on today

₹44,345

Returns

₹55,655

(-55.65%)

Returns from Biohaven Stock

₹60,939 (-60.94%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Biohaven Stock

-43.4%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in Biohaven Shares from India has dropped by -43.4% over the past 30 days, indicating reduced transactional activity.

57%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Biohaven Stock from India on INDmoney has increased by 57% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Biohaven Ltd

  • Name

    Holdings %

  • Vanguard Group Inc

    9.15%

  • BlackRock Inc

    7.40%

  • Stifel Financial Corp

    6.53%

  • Suvretta Capital Management, LLC

    5.56%

  • HHG PLC

    5.00%

  • Farallon Capital Management, L.L.C.

    4.76%

Analyst Recommendation on Biohaven Stock

Rating
Trend

Buy

    94%Buy

    5%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Biohaven(by analysts ranked 0 to 5 stars)

Biohaven Share Price Target

What analysts predicted

Upside of 206.32%

Target:

$47.14

Current:

$15.39

Biohaven share price target is $47.14, a slight Upside of 206.32% compared to current price of $15.39 as per analysts' prediction.

Biohaven Stock Insights

  • Price Movement

    In the last 6 months, BHVN stock has moved down by -58.6%
  • BHVN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 130.8%
  • BHVN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 202.3%

Biohaven Technicals Summary

Sell

Neutral

Buy

Biohaven is currently in a neutral trading position according to technical analysis indicators.

Biohaven Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Biohaven Ltd logo
1.99%
-51.97%
-59.65%
-89.72%
-75.08%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

Biohaven Dividend announcements

  • Biohaven Earnings

    Biohaven’s price-to-earnings ratio stands at None

About Biohaven Ltd

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide. The company develops troriluzole, which is in Phase 3 trial for the treatment of neurological and neuropsychiatric illnesses; taldefgrobep alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 3 clinical trial for the treatment of focal and generalized epilepsy, and major depressive disorder; BHV-2100 that is in Phase 2 clinical trial for the treatment of migraines and pain disorders; BHV-1510, which is in Phase ½ trial that targets advanced or metastatic epithelial tumors; and BHV-8000, a product candidate that completed Phase 1 clinical trial for the treatment of Alzheimer's and Parkinson's disease, and multiple sclerosis, as well as prevention of amyloid-related imaging abnormalities. It is also developing BHV-1300, which in Phase 1 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 1 trial for IgA nephropathy; BHV-1100, which is in Phase 1 trial for multiple myeloma patients; BHV-1600, which is in Phase 1 trial for the treatment of peripartum cardiomyopathy; BHV-1310 that is in preclinical trial for the treatment of generalized myasthenia gravis and other acute exacerbations or flares; BHV-1530, which is in preclinical trial to treat urothelial cancer; BHV-1500 that is in preclinical trial for Hodgkin's lymphoma; and BHV-5500 that blocks glutamate signaling mediated by post-synaptic NMDA receptors. The company has strategic partnerships with Merus N.V., GeneQuantum Healthcare (Suzhou) Co. Ltd., Aimed Bio, Inc., Yale University, Katholieke Universiteit Leuven, Bristol Meyers Squibb, and Hangzhou Highlightll Pharmaceutical Co. Ltd. Biohaven Ltd. was formerly known as Biohaven Research Ltd. and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut. was formerly known as Biohaven Research Ltd. and c
Organization
Biohaven
Employees
256
CEO
Dr. Vladimir Coric M.D.
Industry
Health Technology

Key Management of Biohaven Ltd

NameTitle
Dr. Vladimir Coric M.D.
Chairman & CEO
Mr. Matthew Buten
Chief Financial Officer
Dr. Bruce D. Car DACVP, Ph.D.
Chief Scientific Officer
Ms. Kimberly Gentile
Senior Vice President of Clinical Operations
Ms. Deb Young
Senior Director of Regulatory Affairs & Operations
Mr. George C. Clark CPA
VP & Chief Accounting Officer
Ms. Jennifer Porcelli
Vice President of Investor Relations
Mr. Warren Volles J.D.
General Counsel & Chief Legal Officer
Mr. Clifford Bechtold M.S.
President, GM of Biohaven Ireland & Chief Compliance Officer
Mr. John Tilton
Chief Commercial Officer of Rare Diseases

Important FAQs about investing in BHVN Stock from India :

What is Biohaven share price today?

Biohaven share price today is $15.39 as on at the close of the market. Biohaven share today touched a day high of $15.70 and a low of $15.31.

What is the 52 week high and 52 week low for Biohaven share?

Biohaven share touched a 52 week high of $55.70 and a 52 week low of $12.79. Biohaven stock price today i.e. is closed at $15.39, lower by 72.37% versus the 52 week high.

How to invest in Biohaven Stock (BHVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biohaven on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biohaven Shares that will get you 0.0975 shares as per Biohaven share price of $15.39 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Biohaven Stock (BHVN) from India?

Indian investors can start investing in Biohaven (BHVN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Biohaven stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Biohaven share’s latest price of $15.39 as on August 30, 2025 at 1:29 am IST, you will get 0.6498 shares of Biohaven. Learn more about fractional shares .

What are the returns that Biohaven has given to Indian investors in the last 5 years?

Biohaven stock has given -75.08% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?